• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, August 21, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

IADR/AADR divests sugar-sweetened beverage companies from investment portfolio

Bioengineer by Bioengineer
January 15, 2019
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Alexandria, VA, USA – The International Association for Dental Research (IADR) and the American Association for Dental Research (AADR) announce the divestment of sugar-sweetened beverage companies from their investment portfolios. While IADR and AADR did not have direct investments in such companies, they’ve changed to investment managers who will screen out any holdings in the sector. The IADR and AADR already exclude any investments in tobacco companies.

The scientific evidence is clear that sugars are the most important dietary factor in the development of dental caries. Sugar-sweetened beverages are a major source of dietary sugars, lack nutritional value, and contribute not only to dental caries, but to unhealthy weight gain, obesity, and increased risk for diabetes and cardiovascular disease. Investing in companies that manufacture or distribute sugar-sweetened beverages or funds that have such holdings is inconsistent with the Missions of IADR and AADR which are to advance research and increase knowledge for the improvement of oral health worldwide.

“There is robust research that identifies free sugars as a major cause of dental caries and sugar-sweetened beverages are a major source of free sugars and are linked to a number of non-communicable diseases,” said AADR President Maria Emanuel Ryan. IADR President Rena D’Souza continued, “the initiative to remove all investments in sugar-sweetened beverage companies, matches IADR/AADR’s previous divestment of tobacco stocks and more clearly embodies our investment philosophy and health-based values.”

The IADR and AADR call on other health-related professional associations with investment portfolios to adopt similar policies regarding sugar-sweetened beverage companies.

###

For press inquiries or more information, please contact Elise Bender [email protected].

About the International Association for Dental Research

The International Association for Dental Research (IADR) is a nonprofit organization with over 11,400 individual members worldwide, dedicated to: (1) advancing research and increasing knowledge for the improvement of oral health worldwide, (2) supporting and representing the oral health research community, and (3) facilitating the communication and application of research findings. To learn more, visit http://www.iadr.org. The American Association for Dental Research (AADR) is the largest Division of IADR with 3,300 members in the United States. To learn more, visit http://www.iadr.org/aadr.

Media Contact
Elise Bender
[email protected]
http://www.iadr.org/IADR/About-Us/News/ArtMID/132983/ArticleID/596/IADRAADR-Divests-Sugar-sweetened-Beverage-Companies-from-Investment-Portfolio

Tags: Dentistry/Periodontal DiseaseDiet/Body WeightMedicine/Health
Share12Tweet8Share2ShareShareShare2

Related Posts

Epilepsy Drugs Successfully Reverse Autism Symptoms in Mice, New Study Finds

Epilepsy Drugs Successfully Reverse Autism Symptoms in Mice, New Study Finds

August 21, 2025
Fluorescent Protein Powers Next-Gen Spin Qubit

Fluorescent Protein Powers Next-Gen Spin Qubit

August 21, 2025

Study Finds Few Depressed Teens Receive Treatment

August 20, 2025

Nitroxoline: New Inhibitor of NLRP3 Pyroptosis

August 20, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Molecules in Focus: Capturing the Timeless Dance of Particles

    141 shares
    Share 56 Tweet 35
  • Neuropsychiatric Risks Linked to COVID-19 Revealed

    81 shares
    Share 32 Tweet 20
  • Modified DASH Diet Reduces Blood Sugar Levels in Adults with Type 2 Diabetes, Clinical Trial Finds

    60 shares
    Share 24 Tweet 15
  • Predicting Colorectal Cancer Using Lifestyle Factors

    47 shares
    Share 19 Tweet 12

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Groundbreaking Supernova Discovery Unveils the Inner Secrets of a Dying Star

Illuminating Tissue Origami: Harnessing Light to Explore and Manipulate Tissue Folding

Epilepsy Drugs Successfully Reverse Autism Symptoms in Mice, New Study Finds

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.